Stockreport

Pfenex Appoints Dr. Steve Kay to Scientific Advisory Board

PFENEX INC  (PFNX) 
NASDAQ:AMEX Investor Relations: pfenex.com
PDF SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging [Read more]